03:48 AM EDT, 07/15/2024 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) filed a registration statement Friday for the potential sale of up to 2.4 million of its common stock on behalf of selling shareholders.

The shares are issuable upon the exercise of certain warrants issued to the selling stockholders. The company will not receive any proceeds from the potential sale.

CNS Pharmaceuticals ( CNSP ) estimates a maximum of roughly $4.4 million in gross proceeds from the cash exercise of the warrants. It plans to use these proceeds for working capital purposes.

Price: 1.2203, Change: -0.01, Percent Change: -0.79